# Evaluation of a Simple-Prep Controlled Embolic

> **NCT06453642** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Fluidx Medical Technology, Inc.** · enrollment: 114 (actual)

## Conditions studied

- Embolization
- Vascular Tumor
- Renal Angiomyolipoma
- Renal Cell Carcinoma
- Bone Tumor
- Portal Vein Embolization

## Interventions

- **DEVICE:** GPX® Embolic Device

## Key facts

- **NCT ID:** NCT06453642
- **Lead sponsor:** Fluidx Medical Technology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-11-18
- **Primary completion:** 2026-05
- **Final completion:** 2026-09
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2026-03-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06453642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06453642, "Evaluation of a Simple-Prep Controlled Embolic". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06453642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*